Proud of the award as “Germany’s innovation leader 2020”: Klaus Kiesel, Chief Executive Officer and Christoph Ulrich, Managing Partner (from left to right).
The medical technology manufacturer from Ulm holds its own against a total of 150,000 German companies
Ulm, July 2020. In this year’s study carried out by the F.A.Z Institute in cooperation with the Institute for Management and Economic Research (IMWF) as well as scientific associate Prognos, ulrich medical has been named one of Germany’s innovation leaders for the year 2020. The comparison is based on an international patent analysis over the last ten years.
This year, a total of 150,000 German companies went under the microscope to determine their innovative strength. The study is based on a scientifically sound analysis of data from the EPO Worldwide Patent Statistical Database (PATSTAT) of the European Patent Office. This database contains over 100 million patents from all leading industrialized and developing countries and this means that it provides an overview of all economically significant countries in the world. This also includes the patents from the two product areas of Contrast Media Injectors and Spinal Implants from ulrich medical. The decisive factor in determining which companies are leading innovators was how often a patent is cited by other patents, in other words how strongly it influences other patents. Another point that was examined was the extent to which the development of the patent differs from others. The fewer patents cited, the more innovative the idea is. All in all, this was able to give an overview of the international impact and interaction of patents and patent families over the past ten years.
Innovative strength from Ulm
ulrich medical is in good company as Germany’s innovation leader for 2020. After all, it was mainly companies from research & development such as Siemens AG, Audi AG or the German Aerospace Center (DLR) that secured a spot among the award winners in 2020. Klaus Kiesel, Chief Executive Officer at ulrich medical, sees the award as confirmation that the company strategy for recent years has worked: “Now that our achievements have been recognized, this shows us that our consistent focus on developing future-oriented technologies and products that live up to “Made in Germany” quality is exactly on point.” Managing Partner, Christoph Ulrich, agrees and adds: “This secures our sustainable and successful growth in the long term and also strengthens confidence in ulrich medical as a strong partner and attractive employer.”
The special publication on the study is available online on the Frankfurter Allgemeine Zeitung newspaper website at https://www.faz.net/asv/deutschlands-innovationsfuehrer.
About ulrich medical
Since it was founded as a family business back in 1912, ulrich medical has been developing, producing and selling cutting-edge medical technology that makes a significant contribution to people’s health and quality of life. Physicians and users worldwide trust in the more than 100 years of expertise the independent company has and it was also one of the first medical technology manufacturers in Germany to be successfully MDR-audited. As one of the few companies in the industry, ulrich medical consistently focuses on achieving the “Made in Germany” quality by developing and producing its products in Germany. The Ulm-based medical technology manufacturer is a renowned specialist in the product areas of Spinal Implants and Contrast Media Injectors. The Spinal Systems division is characterized by our internationally established implants, which are mainly made of titanium and are used for injuries and diseases that have occurred on any part of the spine. In the field of Contrast Media Injectors for CT and MRI, ulrich medical offers specially developed user solutions that support radiologists with modern diagnostic imaging. Their user-friendly operation, outstanding quality and proven hygienic safety make them indispensable in everyday practice and were among the reasons for the coveted approval in the USA, the world’s largest medical technology market.